Current Dermatology Reports is a distinguished journal published by SPRINGER that focuses on the latest advancements and research in the field of dermatology. With an ISSN of 2162-4933, this journal provides a vital platform for clinicians, researchers, and students to disseminate groundbreaking findings and emerging trends pertinent to skin health. Notably recognized within the Q2 category in Dermatology for 2023, it ranks 50th out of 142 journals in the Scopus database, placing it in the 65th percentile among its peers. This accessible journal, which has been converging scholarly contributions since its establishment in 2012, plays a crucial role in bridging the gap between clinical practice and research, thereby enhancing patient care and advancing scientific understanding of skin-related issues. The editorial team is committed to the rigorous peer-review process, ensuring high-quality publications that reflect the evolving landscape of dermatology. Researchers and healthcare professionals are invited to contribute and engage with content that pushes the boundaries of knowledge in this dynamic discipline.

Przeglad Dermatologiczny is a peer-reviewed open-access journal published by TERMEDIA PUBLISHING HOUSE LTD, based in Poland. Since its establishment in 1951, this journal has been dedicated to advancing the field of dermatology by providing a platform for the dissemination of original research, reviews, and clinical case studies. With an e-ISSN of 2084-9893, it has gained recognition within the academic community, despite its current classification in the Q4 quartile of dermatological journals. The journal has been openly accessible since 2009, promoting wider dissemination of scientific knowledge, and is crucial for researchers, professionals, and students alike. While it holds a current rank of #105 out of 142 in the Scopus Dermatology category, the journal continually strives to enhance its impact through quality publications that address pressing dermatological issues. The diverse range of topics covered in the journal ensures it remains a vital resource for those looking to stay informed on the latest developments in dermatological research.

Dermatology Reports is a reputable open-access journal dedicated to advancing the field of dermatology through innovative research and clinical studies. Published by PAGEPRESS PUBL, this journal has been providing unrestricted access to valuable scientific content since 2009, promoting the dissemination of cutting-edge knowledge among researchers, professionals, and students alike. With an ISSN of 2036-7392 and an E-ISSN of 2036-7406, Dermatology Reports is indexed in Scopus, currently holding a rank of 93/142 in the Medicine - Dermatology category, placing it in the 34th percentile. The journal, based in Italy at MEDITGROUP, VIA G BELLI, 4, PAVIA 27100, aims to foster a multidisciplinary approach to dermatological research and practice, with a vision to converge various aspects of the field from 2010 to 2024 and beyond. With its Q3 quartile ranking in 2023, Dermatology Reports stands as a critical platform for highlighting novel findings and therapeutic strategies that shape the future of dermatological science.

Skin Appendage Disorders, published by KARGER, is an esteemed academic journal focusing on the intricate realm of dermatology, particularly the structure and function of skin appendages. Established in 2016 and projected to continue through 2024, this journal has swiftly gained recognition, securing a respectable Q2 ranking in the field of Dermatology as of 2023, and achieving a Scopus rank of 76 out of 142 in the same category. With an ISSN of 2296-9195 and an E-ISSN of 2296-9160, the journal presents a platform for innovative research and clinical findings that address the multifaceted aspects of skin appendage disorders. Researchers, practitioners, and students will find significant value in its open access model, which encourages widespread dissemination of knowledge and fosters collaboration within the dermatological community. By publishing high-quality peer-reviewed articles, Skin Appendage Disorders aims to elevate the understanding of dermatological conditions and contribute to advancements in therapeutic practices, making it a vital resource for those dedicated to skin health.

The Indian Dermatology Online Journal, an esteemed publication of Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of Dermatology, Immunology, Infectious Diseases, and Medical Microbiology. Since transitioning to an Open Access model in 2010, this journal has democratized access to high-quality research and innovative initiatives within these disciplines. With an impact factor positioned in the Q3 category for 2023 across multiple areas, it reflects a commitment to advancing scientific knowledge and practice. Researchers and clinicians benefit from the rigorously peer-reviewed articles, which cover a broad scope of topics relevant to contemporary challenges in dermatology and its related fields. Citing impressive Scopus rankings and broad accessibility options, The Indian Dermatology Online Journal is vital for professionals seeking the latest developments and peer insights to enhance their expertise and improve patient outcomes.

SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.

Dermatopathology is a pioneering open-access journal dedicated to the field of skin pathology, published by MDPI in Basel, Switzerland. Since its inception in 2014, the journal has provided a vital platform for the dissemination of cutting-edge research, advancements, and clinical studies that aid in the understanding of dermatological diseases at the microscopic level. With its commitment to accessibility and wide-ranging contributions from international researchers, Dermatopathology serves as an essential resource for dermatologists, pathologists, and academics alike. The journal strives to foster innovative collaborations and enhance knowledge within the multidisciplinary sphere of dermatology and pathology, ensuring timely access to valuable information that can influence clinical practices and improve patient outcomes. Researchers are encouraged to submit their original articles, case reports, and reviews, contributing to the growing body of knowledge essential for advancing the field.

Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.

CONTACT DERMATITIS, published by WILEY, is a leading international journal focused on the vital field of dermatology, particularly examining the diagnosis, treatment, and management of contact dermatitis and related skin conditions. With origins dating back to 1975 and a planned convergence period extending to 2024, this esteemed journal serves as a crucial resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge in dermatological practices. In the latest rankings, it has achieved a commendable Q2 classification in Dermatology and Q3 classification in Immunology and Allergy for 2023, underscoring its significance within these dynamic fields. Moreover, it holds a notable ranking of #29/142 in Medicine & Dermatology and #130/233 in Medicine & Immunology and Allergy according to Scopus metrics, placing it in the top tier of scholarly publications. While the journal operates on a subscription basis, its comprehensive reviews, original articles, and insightful research findings are invaluable for pushing the boundaries of current dermatological and immunological knowledge. By fostering a deeper understanding of the complexities of skin reactions and their implications, CONTACT DERMATITIS plays a vital role in connecting research with clinical practice, making it an essential read for anyone engaged in the field.

Dermatitis, published by MARY ANN LIEBERT, INC, is a leading journal that focuses on the study of skin inflammation and allergic reactions, making significant contributions to the fields of Dermatology, Immunology, and Allergy. With an ISSN of 1710-3568 and an E-ISSN of 2162-5220, this peer-reviewed journal serves as a critical platform for researchers, healthcare professionals, and students alike, eager to share and explore groundbreaking findings and developments. Recognized for its impact and rigorous scholarly standards, Dermatitis has achieved a Q2 quartile ranking in dermatology and a Q3 ranking in immunology and allergy as of 2023, underscoring its significance in these vital medical sectors. The journal's Scopus ranking places it in the 84th percentile for dermatology and the 50th percentile for immunology and allergy, reflecting its wide acceptance and influence. With a scope spanning from 2004 to 2024, Dermatitis invites original research, reviews, and clinical updates that advance the understanding of skin disorders and therapy innovations, solidifying its role as an essential resource in enhancing skin health worldwide.